GRObioâs groundbreaking science expands the amino acid alphabet to deliver on the promise of protein-based therapies. Structured around transforming protein therapeutics with new amino acid building blocks to treat incurable diseases, GRO Biosciences is leveraging breakthrough technologies from computational protein design and synthetic biology to develop best-in-class protein therapeutics with enhanced properties. Applying its technology platform to develop improved protein therapeutics for diabetes, growth disorders and autoimmunity, the company has established multiple genomically recoded strains of bacteria that can incorporate non-standard amino acids into proteins to confer increased potency, stability, and targeted delivery.
